In conclusion, a novel necroptosis-related gene signature, comprising five genes (CAMK2A, CHMP4C, IL33, IRF9, and TRAF5), has been developed to predict prognosis in patients with BLCA. This evidence concerns the gene IRF9 and bladder transitional cell carcinoma.